Timing of Royalty Payments. BI shall make all royalty payments within sixty (60) days following the end of each calendar quarter for Net Sales from the previous calendar quarter. ****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. CONFIDENTIAL TREATMENT REQUESTED EXECUTION COPY
Appears in 3 contracts
Samples: Confidential Treatment Requested (Vitae Pharmaceuticals, Inc), Confidential Treatment Requested (Vitae Pharmaceuticals, Inc), Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)
Timing of Royalty Payments. BI shall make all royalty payments within sixty (60) days following the end of each calendar quarter Calendar Quarter for Net Sales from during the previous calendar quarter. ****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. CONFIDENTIAL TREATMENT REQUESTED EXECUTION COPYCalendar Quarter.
Appears in 3 contracts
Samples: License and Collaboration Agreement (Zealand Pharma a/S), License and Collaboration Agreement (Zealand Pharma a/S), License and Collaboration Agreement (Zealand Pharma a/S)
Timing of Royalty Payments. BI shall make all royalty payments within sixty (60) days following the end of each calendar quarter Calendar Quarter for Net Sales from during the previous calendar quarterCalendar Quarter. [****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION] Certain information in this document has been omitted and submitted separately to the Securities and Exchange Commission. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. CONFIDENTIAL TREATMENT REQUESTED EXECUTION COPYConfidential treatment has been requested separately with respect to the omitted portions.
Appears in 1 contract
Samples: License and Collaboration Agreement (Zealand Pharma a/S)
